Limits...
The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective.

Yamashiro H, Cutcliffe N, Dobson S, Fisman D, Gold R - Can J Infect Dis Med Microbiol (2015 Jul-Aug)

Bottom Line: The recently approved four-component meningococcal B (4CMenB) vaccine should be recommended and funded as part of Ontario's routine immunization schedule and should also be mandated for school attendance.Broadly, the goals are to assist individual practitioners in advocating the benefits of 4CMenB vaccination to parents, and to counterbalance recommendations from the National Advisory Committee on Immunization and the Canadian Paediatric Society.Abstract available from the publisher.

View Article: PubMed Central - PubMed

Affiliation: Pediatrics Section, Ontario Medical Association (PSOMA) and Pediatricians Alliance of Ontario (PAO); 'Pediatricians of Ontario'

ABSTRACT
As key stakeholders in immunization policy decisions, the Pediatricians of Ontario held an accredited conference on January 18, 2014, to discuss prevention of invasive meningococcal disease. Five key recommendations were put forth regarding immunization strategies to protect children from meningococcal serogroup B disease. The recently approved four-component meningococcal B (4CMenB) vaccine should be recommended and funded as part of Ontario's routine immunization schedule and should also be mandated for school attendance. Public funding for 4CMenB immunization is justified based on current MenB epidemiology, vaccine coverage, cost effectiveness and acceptability, as well as legal, political and ethical considerations related to 4CMenB immunization, particularly because routine recommendations and funding are currently in place for vaccination against meningococcal serogroups that cause significantly less disease in Canada than MenB. Broadly, the goals are to assist individual practitioners in advocating the benefits of 4CMenB vaccination to parents, and to counterbalance recommendations from the National Advisory Committee on Immunization and the Canadian Paediatric Society.

No MeSH data available.


Related in: MedlinePlus

Role of the Pediatricians of Ontario in influencing immunization policy and funding decisions (eg, four-component meningococcal B vaccine). *Pediatricians of Ontario contribute a critical voice in informing provincial immunization policy decisions (and informing GPs) regarding 4CMenB vaccination; **Pediatricians of Ontario also seeking increased opportunities for direct contribution as key stakeholders on national and jurisdictional immunization advisory committees. BOD Burden of disease; CE Cost effectiveness; CIC Canadian Immunization Committee; CMPA Canadian Medical Protective Association; CPS Canadian Paediatric Society; Dec December; DTC Direct to consumer; GPs General practitioners; HPV Human papillomavirus; LUV Licensed but unfunded; MOHLTC Ministry of Health and Long-Term Care (Ontario); MRFC Meningitis Research Foundation of Canada; NACI National Advisory Committee on Immunization; NDS New drug submission; NIS National Immunization Strategy; PHO Public Health Ontario; PIDAC Provincial Infectious Disease Advisory Committee; P/T Provincial/territorial
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4556178&req=5

f1-jidmm-26-183: Role of the Pediatricians of Ontario in influencing immunization policy and funding decisions (eg, four-component meningococcal B vaccine). *Pediatricians of Ontario contribute a critical voice in informing provincial immunization policy decisions (and informing GPs) regarding 4CMenB vaccination; **Pediatricians of Ontario also seeking increased opportunities for direct contribution as key stakeholders on national and jurisdictional immunization advisory committees. BOD Burden of disease; CE Cost effectiveness; CIC Canadian Immunization Committee; CMPA Canadian Medical Protective Association; CPS Canadian Paediatric Society; Dec December; DTC Direct to consumer; GPs General practitioners; HPV Human papillomavirus; LUV Licensed but unfunded; MOHLTC Ministry of Health and Long-Term Care (Ontario); MRFC Meningitis Research Foundation of Canada; NACI National Advisory Committee on Immunization; NDS New drug submission; NIS National Immunization Strategy; PHO Public Health Ontario; PIDAC Provincial Infectious Disease Advisory Committee; P/T Provincial/territorial

Mentions: The Pediatricians of Ontario position is intended to provide medical opinion, in addition to statements issued by the National Advisory Committee on Immunization (NACI) (6,7) and/or Canadian Immunization Committee, and the Canadian Paediatric Society (8,9). In advocating the benefits of 4CMenB immunization to public health policy makers and to Ontario pediatricians in frontline practice, the present position paper should broaden the use of the 4CMenB vaccine (Figure 1; bold arrows).


The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective.

Yamashiro H, Cutcliffe N, Dobson S, Fisman D, Gold R - Can J Infect Dis Med Microbiol (2015 Jul-Aug)

Role of the Pediatricians of Ontario in influencing immunization policy and funding decisions (eg, four-component meningococcal B vaccine). *Pediatricians of Ontario contribute a critical voice in informing provincial immunization policy decisions (and informing GPs) regarding 4CMenB vaccination; **Pediatricians of Ontario also seeking increased opportunities for direct contribution as key stakeholders on national and jurisdictional immunization advisory committees. BOD Burden of disease; CE Cost effectiveness; CIC Canadian Immunization Committee; CMPA Canadian Medical Protective Association; CPS Canadian Paediatric Society; Dec December; DTC Direct to consumer; GPs General practitioners; HPV Human papillomavirus; LUV Licensed but unfunded; MOHLTC Ministry of Health and Long-Term Care (Ontario); MRFC Meningitis Research Foundation of Canada; NACI National Advisory Committee on Immunization; NDS New drug submission; NIS National Immunization Strategy; PHO Public Health Ontario; PIDAC Provincial Infectious Disease Advisory Committee; P/T Provincial/territorial
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4556178&req=5

f1-jidmm-26-183: Role of the Pediatricians of Ontario in influencing immunization policy and funding decisions (eg, four-component meningococcal B vaccine). *Pediatricians of Ontario contribute a critical voice in informing provincial immunization policy decisions (and informing GPs) regarding 4CMenB vaccination; **Pediatricians of Ontario also seeking increased opportunities for direct contribution as key stakeholders on national and jurisdictional immunization advisory committees. BOD Burden of disease; CE Cost effectiveness; CIC Canadian Immunization Committee; CMPA Canadian Medical Protective Association; CPS Canadian Paediatric Society; Dec December; DTC Direct to consumer; GPs General practitioners; HPV Human papillomavirus; LUV Licensed but unfunded; MOHLTC Ministry of Health and Long-Term Care (Ontario); MRFC Meningitis Research Foundation of Canada; NACI National Advisory Committee on Immunization; NDS New drug submission; NIS National Immunization Strategy; PHO Public Health Ontario; PIDAC Provincial Infectious Disease Advisory Committee; P/T Provincial/territorial
Mentions: The Pediatricians of Ontario position is intended to provide medical opinion, in addition to statements issued by the National Advisory Committee on Immunization (NACI) (6,7) and/or Canadian Immunization Committee, and the Canadian Paediatric Society (8,9). In advocating the benefits of 4CMenB immunization to public health policy makers and to Ontario pediatricians in frontline practice, the present position paper should broaden the use of the 4CMenB vaccine (Figure 1; bold arrows).

Bottom Line: The recently approved four-component meningococcal B (4CMenB) vaccine should be recommended and funded as part of Ontario's routine immunization schedule and should also be mandated for school attendance.Broadly, the goals are to assist individual practitioners in advocating the benefits of 4CMenB vaccination to parents, and to counterbalance recommendations from the National Advisory Committee on Immunization and the Canadian Paediatric Society.Abstract available from the publisher.

View Article: PubMed Central - PubMed

Affiliation: Pediatrics Section, Ontario Medical Association (PSOMA) and Pediatricians Alliance of Ontario (PAO); 'Pediatricians of Ontario'

ABSTRACT
As key stakeholders in immunization policy decisions, the Pediatricians of Ontario held an accredited conference on January 18, 2014, to discuss prevention of invasive meningococcal disease. Five key recommendations were put forth regarding immunization strategies to protect children from meningococcal serogroup B disease. The recently approved four-component meningococcal B (4CMenB) vaccine should be recommended and funded as part of Ontario's routine immunization schedule and should also be mandated for school attendance. Public funding for 4CMenB immunization is justified based on current MenB epidemiology, vaccine coverage, cost effectiveness and acceptability, as well as legal, political and ethical considerations related to 4CMenB immunization, particularly because routine recommendations and funding are currently in place for vaccination against meningococcal serogroups that cause significantly less disease in Canada than MenB. Broadly, the goals are to assist individual practitioners in advocating the benefits of 4CMenB vaccination to parents, and to counterbalance recommendations from the National Advisory Committee on Immunization and the Canadian Paediatric Society.

No MeSH data available.


Related in: MedlinePlus